SLDB
Solid Biosciences Inc.
+0.10 (+1.20%)8.83USD438K成交股數946M市值–本益比(近四季)116.9股價營收比–營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 44.3M | 46.1M | 38.1M | 38.9M | 32.4M | 30.9M | 27.3M | 19.5M | 18.9M | 15.5M | 16.7M | 19.8M |
| 銷售管理費用 | 13.1M | 11.2M | 11.3M | 9.2M | 9.3M | 9.1M | 7.9M | 8.3M | 8.0M | 6.8M | 6.4M | 7.1M |
| 營業利益 | −57.4M+38% | −57.3M+43% | −49.4M+40% | −48.1M+73% | −41.7M+55% | −40.1M+80% | −35.2M+52% | −27.8M+4% | −26.9M | −22.3M | −23.1M | −26.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −54.8M+39% | −56.7M+44% | −49.8M+52% | −45.8M+83% | −39.5M+62% | −39.3M+93% | −32.7M+56% | −25.1M+2% | −24.3M | −20.3M | −21.0M | −24.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.38-10% | -0.52-12% | -0.50-37% | -0.48-21% | -0.42-34% | -0.59-40% | -0.79-25% | -0.61-51% | -0.64 | -0.99 | -1.05 | -1.25 |
| 稀釋股數 | 144M | 110M | 87.5M | 94.4M | 94.1M | 66.3M | 41.4M | 40.9M | 38.2M | 19.9M | 20.1M | 19.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 159M | 297M | 59.9M | 61.4M | 139M | 211M | 64.4M | 95.9M | 118M | 74.0M | 49.0M | 91.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 421M | 423M | 233M | 274M | 308M | 344M | 212M | 231M | 249M | 165M | 185M | 205M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 46.5M | 48.8M | 52.5M | 56.0M | 50.0M | 49.4M | 44.8M | 37.7M | 38.0M | 38.5M | 40.4M | 41.0M |
| 股東權益 | 374M | 374M | 180M | 218M | 258M | 294M | 167M | 193M | 211M | 126M | 144M | 164M |
| 負債比 | 11.1% | 11.5% | 22.6% | 20.4% | 16.2% | 14.4% | 21.2% | 16.3% | 15.3% | 23.3% | 21.9% | 20.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −47.2M+48% | – | – | – | −31.9M | – | – | −25.2M | – | – | – |
| 資本支出 | – | 165K | – | – | – | 126K | – | – | 149K | – | – | – |
| 自由現金流 | – | −47.4M+48% | – | – | – | −32.0M | – | – | −25.3M | – | – | – |
| 折舊攤銷 | – | 395K | – | – | – | 407K | – | – | 327K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −174M | –% | -1.99 | −157M |
| FY2024 | – | – | −125M | –% | -3.06 | −101M |
| FY2023 | – | – | −96.0M | –% | -4.83 | −95.7M |
| FY2022 | 8.1M | -40.6% | −86.0M | -1,062.3% | -10.10 | −101M |
| FY2021 | 13.6M | – | −72.2M | -530.0% | -10.14 | −79.0M |
| FY2020 | 0.00 | – | −88.3M | –% | -25.50 | −57.5M |
| FY2019 | 0.00 | – | −117M | –% | -2.91 | −97.1M |
| FY2018 | 0.00 | – | −74.8M | –% | -2.25 | −78.0M |